Program

The program will include sessions on:

Small molecule modulation of stem cell differentiation
Development of disease models using gene editing of hESCs and patient-derived iPSCs
Instrumental methods for phenotypic chemical library screening
3D cell culture models and organoids in disease modelling
Future uses of stem cell technology in the pharmaceutical industry

Full program will be available from early 2018.